SCHEMBL10071962

SCHEMBL10071962

c1ccc(CN2CCC3(CC2)CC3CNc2ccc(Oc3ccccc3)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.57
ACHE P22303 2/20 0.52
BACE1 P56817 2/20 0.52
CHRM4 P08173 1/20 0.45
LTA4H P09960 3/20 0.45
FAAH O00519 1/20 0.44
NAMPT P43490 1/20 0.43
PRKAA2 P54646 1/20 0.42
MCHR2 Q969V1 1/20 0.42
MCHR1 Q99705 1/20 0.42
MMP2 P08253 2/20 0.42
MMP9 P14780 2/20 0.42
ADAMTS4 O75173 1/20 0.41
MMP1 P03956 1/20 0.41
MMP3 P08254 1/20 0.41
MMP7 P09237 1/20 0.41
MMP8 P22894 1/20 0.41
MMP13 P45452 1/20 0.41
MMP14 P50281 1/20 0.41
ADAM17 P78536 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709213 0.80 SCN9A (0.58) SCN9AACHEBACE1NAMPTCYP3A4
SCHEMBL10072406 0.79 SCN9A (0.57) SCN9AACHEBACE1NAMPTCYP3A4
SCHEMBL10071963 0.78 SCN9A (0.56) SCN9AACHEBACE1FAAHNAMPT
SCHEMBL1709232 0.73 SCN9A (1.00) SCN9AACHEBACE1NAMPTCYP3A4
SCHEMBL19567897 0.72 OPRM1 (0.45) LTA4HFAAHMCHR1CCR5CYP3A4
SCHEMBL18860348 0.71 NAMPT (0.48) SCN9ANAMPT
SCHEMBL1709211 0.71 SCN9A (0.59) SCN9AACHEBACE1NAMPT
SCHEMBL1709247 0.71 SCN9A (0.64) SCN9ANAMPTCYP3A4
SCHEMBL1709234 0.70 SCN9A (0.60) SCN9AACHEBACE1NAMPTCYP3A4
SCHEMBL381873 0.70 OPRL1 (0.75) MMP2MMP9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012047703-A2 CYCLOPROPYL-SPIRO-PIPERIDINES USEFUL AS SODIUM CHANNEL BLOCKERS SCHERING CORPORATION (US) 2012-04-12 WO disclosed